271 related articles for article (PubMed ID: 29146546)
1. Signaling via toll-like receptor 4 and CD40 in B cells plays a regulatory role in the pathogenesis of multiple sclerosis through interleukin-10 production.
Okada Y; Ochi H; Fujii C; Hashi Y; Hamatani M; Ashida S; Kawamura K; Kusaka H; Matsumoto S; Nakagawa M; Mizuno T; Takahashi R; Kondo T
J Autoimmun; 2018 Mar; 88():103-113. PubMed ID: 29146546
[TBL] [Abstract][Full Text] [Related]
2. Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.
Rip J; de Bruijn MJW; Appelman MK; Pal Singh S; Hendriks RW; Corneth OBJ
Front Immunol; 2019; 10():95. PubMed ID: 30761150
[TBL] [Abstract][Full Text] [Related]
3. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
[TBL] [Abstract][Full Text] [Related]
4. Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-positive B-cell population.
Doi H; Iyer TK; Carpenter E; Li H; Chang KM; Vonderheide RH; Kaplan DE
Hepatology; 2012 Mar; 55(3):709-19. PubMed ID: 21932384
[TBL] [Abstract][Full Text] [Related]
5. Distinct TLR-mediated cytokine production and immunoglobulin secretion in human newborn naïve B cells.
Pettengill MA; van Haren SD; Li N; Dowling DJ; Bergelson I; Jans J; Ferwerda G; Levy O
Innate Immun; 2016 Aug; 22(6):433-43. PubMed ID: 27252169
[TBL] [Abstract][Full Text] [Related]
6. Receptor cross-talk spatially restricts p-ERK during TLR4 stimulation of autoreactive B cells.
Lee SR; Rutan JA; Monteith AJ; Jones SZ; Kang SA; Krum KN; Kilmon MA; Roques JR; Wagner NJ; Clarke SH; Vilen BJ
J Immunol; 2012 Oct; 189(8):3859-68. PubMed ID: 22984080
[TBL] [Abstract][Full Text] [Related]
7. CD27 synergizes with CD40 to induce IgM, IgG, and IgA antibody responses of peripheral blood B cells in the presence of IL-2 and IL-10.
Hirano T; Yonekubo I; Shimo K; Mizuguchi J
Immunol Lett; 2003 Oct; 89(2-3):251-7. PubMed ID: 14556986
[TBL] [Abstract][Full Text] [Related]
8. Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis.
Hirotani M; Niino M; Fukazawa T; Kikuchi S; Yabe I; Hamada S; Tajima Y; Sasaki H
J Neuroimmunol; 2010 Apr; 221(1-2):95-100. PubMed ID: 20227772
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the Interleukin-21 Pathway with Interleukin-4 Distinguishes Common Variable Immunodeficiency Patients with More Non-infectious Clinical Complications.
Desjardins M; Béland M; Dembele M; Lejtenyi D; Drolet JP; Lemire M; Tsoukas C; Ben-Shoshan M; Noya FJD; Alizadehfar R; McCusker CT; Mazer BD
J Clin Immunol; 2018 Jan; 38(1):45-55. PubMed ID: 29103189
[TBL] [Abstract][Full Text] [Related]
10. Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation.
Carpenter EL; Mick R; Rüter J; Vonderheide RH
J Transl Med; 2009 Nov; 7():93. PubMed ID: 19906293
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation.
Howell J; Sawhney R; Testro A; Skinner N; Gow P; Angus P; Ratnam D; Visvanathan K
Liver Transpl; 2013 Oct; 19(10):1099-107. PubMed ID: 23894100
[TBL] [Abstract][Full Text] [Related]
12. Amplification of Toll-like receptor-mediated signaling through spleen tyrosine kinase in human B-cell activation.
Iwata S; Yamaoka K; Niiro H; Nakano K; Wang SP; Akashi K; Tanaka Y
J Allergy Clin Immunol; 2012 Jun; 129(6):1594-601.e2. PubMed ID: 22541243
[TBL] [Abstract][Full Text] [Related]
13. Frequency and immunophenotype of IL10-producing regulatory B cells in optic neuritis.
Lundqvist S; Modvig S; Fischer EA; Frederiksen JL; Degn M
Immunology; 2019 Mar; 156(3):259-269. PubMed ID: 30452090
[TBL] [Abstract][Full Text] [Related]
14. Decreased production of interleukin-10 and transforming growth factor-β in Toll-like receptor-activated intestinal B cells in SAMP1/Yit mice.
Mishima Y; Ishihara S; Aziz MM; Oka A; Kusunoki R; Otani A; Tada Y; Li YY; Moriyama I; Oshima N; Yuki T; Amano Y; Matsumoto S; Kinoshita Y
Immunology; 2010 Dec; 131(4):473-87. PubMed ID: 20561083
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine efficiently suppresses inflammatory responses of human class-switched memory B cells via Toll-like receptor 9 inhibition.
Torigoe M; Sakata K; Ishii A; Iwata S; Nakayamada S; Tanaka Y
Clin Immunol; 2018 Oct; 195():1-7. PubMed ID: 29981383
[TBL] [Abstract][Full Text] [Related]
16. Interferon-Beta Treatment Differentially Alters TLR2 and TLR4-Dependent Cytokine Production in Multiple Sclerosis Patients.
Oliveira IBN; Gomes RS; Gomides LF; Dos Santos JC; Carneiro MAD; Ribeiro-Dias F; Diniz DS
Neuroimmunomodulation; 2019; 26(2):77-83. PubMed ID: 30897575
[TBL] [Abstract][Full Text] [Related]
17. IFN-γ stimulates CpG-induced IL-10 production in B cells via p38 and JNK signalling pathways.
Imbrechts M; De Samblancx K; Fierens K; Brisse E; Vandenhaute J; Mitera T; Libert C; Smets I; Goris A; Wouters C; Matthys P
Eur J Immunol; 2018 Sep; 48(9):1506-1521. PubMed ID: 30004580
[TBL] [Abstract][Full Text] [Related]
18. Age-Associated B Cells with Proinflammatory Characteristics Are Expanded in a Proportion of Multiple Sclerosis Patients.
Claes N; Fraussen J; Vanheusden M; Hellings N; Stinissen P; Van Wijmeersch B; Hupperts R; Somers V
J Immunol; 2016 Dec; 197(12):4576-4583. PubMed ID: 27837111
[TBL] [Abstract][Full Text] [Related]
19. Helminth infections associated with multiple sclerosis induce regulatory B cells.
Correale J; Farez M; Razzitte G
Ann Neurol; 2008 Aug; 64(2):187-99. PubMed ID: 18655096
[TBL] [Abstract][Full Text] [Related]
20. CD24(hi)CD27(+) B cells from patients with allergic asthma have impaired regulatory activity in response to lipopolysaccharide.
van der Vlugt LE; Mlejnek E; Ozir-Fazalalikhan A; Janssen Bonas M; Dijksman TR; Labuda LA; Schot R; Guigas B; Möller GM; Hiemstra PS; Yazdanbakhsh M; Smits HH
Clin Exp Allergy; 2014 Apr; 44(4):517-28. PubMed ID: 24261983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
